An interventional study of Integrated Mobile Health Platform in Mobile Health Platform and Clinical Outcomes, sponsored by Sohag University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-26.
Sponsored by Sohag University · Not applicable, Interventional, and Treatment
This study will aim to examine the Effect of integrated Mobile Health Platform on early detection of clinical outcomes of Critical ill patients.
This study clarify if using if using the electric platform will reduce the complications in critical ill patients this complications include respiratory complications, renal complications, cardiac complications
Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Critically ill patients in the ICU managed using the integrated Mobile Health (mHealth) platform, where real-time patient data and automated early warning scores trigger immediate mobile alerts for clinicians.
Device: Integrated Mobile Health Platform
Critically ill patients in the ICU receiving standard clinical monitoring and conventional early deterioration detection protocols without the use of the mHealth platform.
A digital health platform integrated with ICU monitoring systems to automatically collect, record, and analyze patient vital signs and lab trends, generating real-time early warning alerts for healthcare providers.
ICU Mortality Rate
The percentage of critically ill patients who die in the General Intensive Care Unit during their hospital stay. This will evaluate the impact of the mHealth platform on reducing patient mortality.
Time frame: From ICU admission up to 30 days.
ICU Length of Stay (LOS)
The total number of days each patient spends in the General Intensive Care Unit from the day of admission until discharge.
Time frame: From ICU admission up to 30 days.
Incidence of Clinical Complications
The occurrence of organ-specific complications during the ICU stay, including respiratory (pulmonary edema, ARDS, pneumonia, difficult weaning), cardiac (cardiac arrest, shock, arrhythmia), and renal complications (acute renal failure).
Time frame: Daily from study enrollment until ICU discharge, up to 30 days.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — De-identified individual participant data underlying the final results of this study will be made available to ensure transparency and promote collaborative scientific research.
Supporting information: Study protocol, Informed consent form
Time frame: Data will become available 6 months after publication of the main study results and will remain accessible for up to 3 years.
Access criteria: Data will be shared with qualified researchers upon reasonable formal request directed to the primary investigator for the purpose of secondary scientific analysis.
Started May 2026 (actual). Primary completion is estimated for Dec 2026, 7 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 26, 2026: start Jul 2026 → May 2026 and primary completion Apr 2027 → Dec 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.